World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
74
Citations
26087
World Ranking
5485
National Ranking
422

Klaus Okkenhaug publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Klaus Okkenhaug sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 156 publications — 30th percentile

30% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Klaus Okkenhaug D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Klaus Okkenhaug sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 74 D-Index — 72nd percentile

72% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Klaus Okkenhaug is affiliated with the University of Cambridge in the United Kingdom. Their research career centers primarily on immunology and microbiology, with significant contributions also made in the fields of medicine, molecular biology, oncology, genetics, and epidemiology.

Their most recent published papers include:

  • PI3K inhibitors are finally coming of age, 2021, Nature Reviews Drug Discovery
  • Tumors induce de novo steroid biosynthesis in T cells to evade immunity, 2020, Nature Communications
  • CCR8 marks highly suppressive Treg cells within tumours but is dispensable for their accumulation and suppressive function, 2021, Immunology
  • Cholesterol metabolism drives regulatory B cell IL-10 through provision of geranylgeranyl pyrophosphate, 2020, Nature Communications
  • Intermittent PI3Kδ inhibition sustains anti-tumour immunity and curbs irAEs, 2022, Nature

Okkenhaug's frequent co-authors include:

  • Rahul Roychoudhuri
  • Charlotte J. Imianowski
  • Sarah K. Whiteside
  • Paula Kuo
  • Anita Chandra

The main publication venues for their work include:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Nature Communications
  • Frontiers in Immunology
  • Nature Reviews Drug Discovery
  • Nature

Research topics covered in their publications embrace the following areas:

  • Immune Cell Function and Interaction
  • T-cell and B-cell Immunology
  • Immunotherapy and Immune Responses
  • CAR-T cell therapy research
  • Immune cells in cancer
  • Chronic Lymphocytic Leukemia Research
  • Cancer Immunotherapy and Biomarkers

Okkenhaug's body of work demonstrates a focus on understanding immune cell mechanisms and interactions, with particular emphasis on T-cell and B-cell immunology as well as their roles in cancer and immunotherapy. Their research includes exploration of targeted therapies such as PI3K inhibitors and investigations into immune evasion by tumors.

Best Publications

  • Requirement of bic/microRNA-155 for normal immune function.

    Antony Rodriguez;Elena Vigorito;Simon Clare;Madhuri V. Warren;Madhuri V. Warren

  • Cellular function of phosphoinositide 3-kinases: Implications for development, immunity, homeostasis, and cancer

    Roy Katso;Klaus Okkenhaug;Khatereh Ahmadi;Sarah White

  • Ribosomal Protein S6 Kinase 1 Signaling Regulates Mammalian Life Span

    Colin Selman;Jennifer M A Tullet;Daniela Wieser;Elaine Elizabeth Irvine

  • Impaired B and T Cell Antigen Receptor Signaling in p110δ PI 3-Kinase Mutant Mice

    Klaus Okkenhaug;Antonio Bilancio;Géraldine Farjot;Helen Priddle

  • PI3K in lymphocyte development, differentiation and activation

    Klaus Okkenhaug;Bart Vanhaesebroeck

  • Ionic immune suppression within the tumour microenvironment limits T cell effector function

    Robert Eil;Suman K. Vodnala;David Clever;Christopher A. Klebanoff;Christopher A. Klebanoff

  • Phosphoinositide 3-Kinase δ Gene Mutation Predisposes to Respiratory Infection and Airway Damage

    Ivan Angulo;Oscar Vadas;Fabien Garçon;Edward Banham-Hall

  • Evidence for lifespan extension and delayed age-related biomarkers in insulin receptor substrate 1 null mice

    Colin Selman;Steven Lingard;Agharul I. Choudhury;Rachel L. Batterham

  • PDK1 regulation of mTOR and hypoxia-inducible factor 1 integrate metabolism and migration of CD8+ T cells

    David K. Finlay;Ella Rosenzweig;Linda V. Sinclair;Carmen Feijoo-Carnero

  • Inactivation of PI(3)K p110δ breaks regulatory T-cell-mediated immune tolerance to cancer

    Khaled Ali;Dalya R. Soond;Roberto Piñeiro;Thorsten Hagemann

  • Critical role for the p110α phosphoinositide-3-OH kinase in growth and metabolic regulation

    Lazaros C. Foukas;Marc Claret;Wayne Pearce;Klaus Okkenhaug;Klaus Okkenhaug

  • Essential role for the p110δ phosphoinositide 3-kinase in the allergic response

    Khaled Ali;Antonio Bilancio;Matthew Thomas;Wayne Pearce

  • Signaling by the Phosphoinositide 3-Kinase Family in Immune Cells

    Klaus Okkenhaug

  • Clinical spectrum and features of activated phosphoinositide 3-kinase δ syndrome: A large patient cohort study.

    Tanya I Coulter;Anita Chandra;Chris M Bacon;Judith Babar

  • Cutting Edge: The Foxp3 Target miR-155 Contributes to the Development of Regulatory T Cells

    Susan Kohlhaas;Oliver A. Garden;Cheryl Scudamore;Martin Turner

  • Phosphatidylinositol-3-OH kinase and nutrient-sensing mTOR pathways control T lymphocyte trafficking.

    Linda V Sinclair;David Finlay;Carmen Feijoo;Georgina H Cornish

  • The p110β isoform of phosphoinositide 3-kinase signals downstream of G protein-coupled receptors and is functionally redundant with p110γ

    Julie Guillermet-Guibert;Katja Bjorklof;Katja Bjorklof;Ashreena Salpekar;Ashreena Salpekar;Cristiano Gonella;Cristiano Gonella

  • Sequential activation of class IB and class IA PI3K is important for the primed respiratory burst of human but not murine neutrophils

    Alison M. Condliffe;Keith Davidson;Karen E. Anderson;Chris D. Ellson

  • Cutting edge: The phosphoinositide 3-kinase p110 delta is critical for the function of CD4(+)CD25(+)Foxp3(+) regulatory T cells

    Daniel T. Patton;Oliver A. Garden;Oliver A. Garden;Wayne P. Pearce;Louise E. Clough

  • Multi-tissue DNA methylation age predictor in mouse

    Thomas M. Stubbs;Marc Jan Bonder;Anne-Katrien Stark;Felix Krueger

Frequent Co-Authors

Bart Vanhaesebroeck
Bart Vanhaesebroeck University College London
Martin R. Turner
Martin R. Turner University of Oxford
Federica M. Marelli-Berg
Federica M. Marelli-Berg Queen Mary University of London
Robert Rottapel
Robert Rottapel University of Toronto
Edwin R. Chilvers
Edwin R. Chilvers Imperial College London
Menna R. Clatworthy
Menna R. Clatworthy University of Cambridge
Phillip T. Hawkins
Phillip T. Hawkins Babraham Institute
Claudia Kemper
Claudia Kemper National Institutes of Health
Len R. Stephens
Len R. Stephens Babraham Institute
Capucine Picard
Capucine Picard Université Paris Cité

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Biology and Biochemistry can open doors to a variety of specialized online degrees and career opportunities in health and science. For those interested in nutrition, pursuing an online dietitian degree offers a flexible route to careers in dietetics and wellness coaching. This path is ideal for students who want to work directly with individuals on their nutritional needs.

Many biochemistry graduates consider nursing. A streamlined way to advance in this field is through rn to bsn online programs, which help registered nurses gain higher qualifications with extra flexibility.

Those aspiring to leadership roles in healthcare settings can look into the fastest online master's in healthcare management programs. These degrees prepare students for managerial positions and healthcare administration.

For graduates interested in mental health and advanced nursing practice, psychiatric np programs offer a direct pathway to becoming a psychiatric mental health nurse practitioner. Online options make gaining these specialized qualifications more accessible than ever before.

Best Scientists Citing Klaus Okkenhaug

Trending Scientists

Recently Published Articles